Association between native T1 mapping of the kidney and renal fibrosis in patients with IgA nephropathy

Abstract Introduction IgA nephropathy (IgAN) is the commonest global cause of glomerulonephritis. Extent of fibrosis, tubular atrophy and glomerulosclerosis predict renal function decline. Extent of renal fibrosis is assessed with renal biopsy which is invasive and prone to sampling error. We assess...

Full description

Bibliographic Details
Main Authors: M. P. Graham-Brown, A. Singh, J. Wormleighton, N. J. Brunskill, G. P. McCann, J. Barratt, J. O. Burton, G. Xu
Format: Article
Language:English
Published: BMC 2019-07-01
Series:BMC Nephrology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12882-019-1447-2
_version_ 1818760113641488384
author M. P. Graham-Brown
A. Singh
J. Wormleighton
N. J. Brunskill
G. P. McCann
J. Barratt
J. O. Burton
G. Xu
author_facet M. P. Graham-Brown
A. Singh
J. Wormleighton
N. J. Brunskill
G. P. McCann
J. Barratt
J. O. Burton
G. Xu
author_sort M. P. Graham-Brown
collection DOAJ
description Abstract Introduction IgA nephropathy (IgAN) is the commonest global cause of glomerulonephritis. Extent of fibrosis, tubular atrophy and glomerulosclerosis predict renal function decline. Extent of renal fibrosis is assessed with renal biopsy which is invasive and prone to sampling error. We assessed the utility of non-contrast native T1 mapping of the kidney in patients with IgAN for assessment of renal fibrosis. Methods Renal native T1 mapping was undertaken in 20 patients with IgAN and 10 healthy subjects. Ten IgAN patients had a second scan to assess test-retest reproducibility of the technique. Native T1 times were compared to markers of disease severity including degree of fibrosis, eGFR, rate of eGFR decline and proteinuria. Results All patients tolerated the MRI scan and analysable quality T1 maps were acquired in at least one kidney in all subjects. Cortical T1 times were significantly longer in patients with IgAN than healthy subjects (1540 ms ± 110 ms versus 1446 ± 88 ms, p = 0.038). There was excellent test-retest reproducibility of the technique, with Coefficient-of-variability of axial and coronal T1 mapping analysis being 2.9 and 3.7% respectively. T1 correlated with eGFR and proteinuria (r = − 0.444, p = 0.016; r = 0.533, p = 0.003 respectively). Patients with an eGFR decline > 2 ml/min/year had increased T1 times compared to those with a decline < 2 ml/min/year (1615 ± 135 ms versus 1516 ± 87 ms, p = 0.068), and T1 time was also higher in patients with a histological ‘T’-score of > 0, compared to those with a ‘T’-score of 0 (1575 ± 106 ms versus 1496 ± 105 ms, p = 0.131), though not to significance. Conclusions Cortical native T1 time is significantly increased in patients with IgAN compared to healthy subjects and correlates with markers of renal disease. Reproducibility of renal T1 mapping is excellent. This study highlights the potential utility of native T1 mapping in IgAN and other progressive nephropathies, and larger prospective studies are warranted.
first_indexed 2024-12-18T06:53:28Z
format Article
id doaj.art-f67e1308b44944528e1e53a32391219d
institution Directory Open Access Journal
issn 1471-2369
language English
last_indexed 2024-12-18T06:53:28Z
publishDate 2019-07-01
publisher BMC
record_format Article
series BMC Nephrology
spelling doaj.art-f67e1308b44944528e1e53a32391219d2022-12-21T21:17:16ZengBMCBMC Nephrology1471-23692019-07-012011710.1186/s12882-019-1447-2Association between native T1 mapping of the kidney and renal fibrosis in patients with IgA nephropathyM. P. Graham-Brown0A. Singh1J. Wormleighton2N. J. Brunskill3G. P. McCann4J. Barratt5J. O. Burton6G. Xu7John Walls Renal Unit, University Hosptials of Leicester NHS TrustDeparment of Cardiovascular Sciences, University of Leicester and NIHR Leicester Cardiovascular Biomedical Research Centre, Glenfield HospitalDeparment of Cardiovascular Sciences, University of Leicester and NIHR Leicester Cardiovascular Biomedical Research Centre, Glenfield HospitalJohn Walls Renal Unit, University Hosptials of Leicester NHS TrustDeparment of Cardiovascular Sciences, University of Leicester and NIHR Leicester Cardiovascular Biomedical Research Centre, Glenfield HospitalJohn Walls Renal Unit, University Hosptials of Leicester NHS TrustJohn Walls Renal Unit, University Hosptials of Leicester NHS TrustJohn Walls Renal Unit, University Hosptials of Leicester NHS TrustAbstract Introduction IgA nephropathy (IgAN) is the commonest global cause of glomerulonephritis. Extent of fibrosis, tubular atrophy and glomerulosclerosis predict renal function decline. Extent of renal fibrosis is assessed with renal biopsy which is invasive and prone to sampling error. We assessed the utility of non-contrast native T1 mapping of the kidney in patients with IgAN for assessment of renal fibrosis. Methods Renal native T1 mapping was undertaken in 20 patients with IgAN and 10 healthy subjects. Ten IgAN patients had a second scan to assess test-retest reproducibility of the technique. Native T1 times were compared to markers of disease severity including degree of fibrosis, eGFR, rate of eGFR decline and proteinuria. Results All patients tolerated the MRI scan and analysable quality T1 maps were acquired in at least one kidney in all subjects. Cortical T1 times were significantly longer in patients with IgAN than healthy subjects (1540 ms ± 110 ms versus 1446 ± 88 ms, p = 0.038). There was excellent test-retest reproducibility of the technique, with Coefficient-of-variability of axial and coronal T1 mapping analysis being 2.9 and 3.7% respectively. T1 correlated with eGFR and proteinuria (r = − 0.444, p = 0.016; r = 0.533, p = 0.003 respectively). Patients with an eGFR decline > 2 ml/min/year had increased T1 times compared to those with a decline < 2 ml/min/year (1615 ± 135 ms versus 1516 ± 87 ms, p = 0.068), and T1 time was also higher in patients with a histological ‘T’-score of > 0, compared to those with a ‘T’-score of 0 (1575 ± 106 ms versus 1496 ± 105 ms, p = 0.131), though not to significance. Conclusions Cortical native T1 time is significantly increased in patients with IgAN compared to healthy subjects and correlates with markers of renal disease. Reproducibility of renal T1 mapping is excellent. This study highlights the potential utility of native T1 mapping in IgAN and other progressive nephropathies, and larger prospective studies are warranted.http://link.springer.com/article/10.1186/s12882-019-1447-2IgA nephropathyRenal fibrosisNative T1 mappingMRI
spellingShingle M. P. Graham-Brown
A. Singh
J. Wormleighton
N. J. Brunskill
G. P. McCann
J. Barratt
J. O. Burton
G. Xu
Association between native T1 mapping of the kidney and renal fibrosis in patients with IgA nephropathy
BMC Nephrology
IgA nephropathy
Renal fibrosis
Native T1 mapping
MRI
title Association between native T1 mapping of the kidney and renal fibrosis in patients with IgA nephropathy
title_full Association between native T1 mapping of the kidney and renal fibrosis in patients with IgA nephropathy
title_fullStr Association between native T1 mapping of the kidney and renal fibrosis in patients with IgA nephropathy
title_full_unstemmed Association between native T1 mapping of the kidney and renal fibrosis in patients with IgA nephropathy
title_short Association between native T1 mapping of the kidney and renal fibrosis in patients with IgA nephropathy
title_sort association between native t1 mapping of the kidney and renal fibrosis in patients with iga nephropathy
topic IgA nephropathy
Renal fibrosis
Native T1 mapping
MRI
url http://link.springer.com/article/10.1186/s12882-019-1447-2
work_keys_str_mv AT mpgrahambrown associationbetweennativet1mappingofthekidneyandrenalfibrosisinpatientswithiganephropathy
AT asingh associationbetweennativet1mappingofthekidneyandrenalfibrosisinpatientswithiganephropathy
AT jwormleighton associationbetweennativet1mappingofthekidneyandrenalfibrosisinpatientswithiganephropathy
AT njbrunskill associationbetweennativet1mappingofthekidneyandrenalfibrosisinpatientswithiganephropathy
AT gpmccann associationbetweennativet1mappingofthekidneyandrenalfibrosisinpatientswithiganephropathy
AT jbarratt associationbetweennativet1mappingofthekidneyandrenalfibrosisinpatientswithiganephropathy
AT joburton associationbetweennativet1mappingofthekidneyandrenalfibrosisinpatientswithiganephropathy
AT gxu associationbetweennativet1mappingofthekidneyandrenalfibrosisinpatientswithiganephropathy